FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Naproxen by Hikma Pharmaceuticals USA Inc., indicating changes to the product's approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Dysmenorrhea
• Gout
• Juvenile Idiopathic Arthritis
• Migraine
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Naproxen (Naproxen)

Snippet

SUPPL AP for NAPROXEN (NAPROXEN)